320
G. SRIDHAR AND G. V. M. SHARMA
and concentrated, and the residue was purified by column chromatography (60- to
120-mesh silica gel, 8% EtOAc in petroleum ether) to afford 24 (0.35 g, 76%) as a yellow
syrup with 100% diastereoselectivity. ½a�25 ¼ þ 61.8 (c 0.5, CHCl3); IR (neat): 3449, 2925,
D
1
2852, 1731, 1633, 1456, 1372, 1247, 1149, 1099, 1032, 958, 917, 749, 699 cmÀ 1; H NMR
(300 MHz, CDCl3): δ 7.49–7.29 (m, 5H, ArH-Bn), 5.40–5.25 (m, 2H, olefinic), 4.69 (m,
4H, benzylic, -OCH2), 4.07–3.83 (m, 2H, 2 � -OCH), 3.74–3.48 (m, 1H, -OCH), 3.38 (s,
6H, 2 � -OCH3), 3.37–3.31 (m, 1H, -OCH), 2.71–2.56 (m, 1H, -CH), 2.35–2.11 (m, 1H,
-CH), 2.35–2.11 (m, 1H, allylic -CH), 2.04–1.84 (m, 1H, allylic -CH), 1.34–1.24 (m, 2H,
allylic -CH2), 1.22 (d, 3H, J ¼ 6.3 Hz, -CH3), 0.98–0.81 (m, 2H, -CH2); 13C NMR (CDCl3,
75 MHz): δ 171.0, 138.8, 133.8, 128.6, 128.1, 127.6, 97.4, 79.6, 74.2, 74.6, 67.3, 67.6, 56.5,
56.2, 38.7, 38.4, 26.8, 28.6, 24.4; HRMS (ESI): m/z calculated for C22H32O6Na [MþNa]þ
415.1132, found 415.1126.
(4R,6S,12S)-6-Hydroxy-4-methoxy-12-methyloxacyclododecane-2,5-dione (1)
A stirred solution of 26 (0.03 g, 0.09 mmol) in THF (20 mL) was cooled to 0 °C, treated with
10% aqueous HCl (1 mL), and stirred at 35 °C for 5 h. The reaction mixture was quenched
with saturated NaHCO3 solution (5 mL) and extracted with EtOAc (2 � 10 mL). The com-
bined organic layers were washed with water (2 � 15 mL) and brine (15 mL), and dried
(Na2SO4). The solvent was evaporated and the residue was purified by column chromato-
graphy (60- to 120-mesh silica gel, 20% EtOAc in petroleum ether) to give 1 (21 mg, 84%)
as a colorless amorphous solid with 100% diastereoselectivity. ½a�2D5 ¼ À 29.1 (c 0.5,
1
CHCl3); IR (neat): 3429, 2934, 1710, 1646, 1220, 1170, 1106, 763, 713 cmÀ 1; H NMR
(300 MHz, CDCl3): δ 4.83–4.81 (m, 1H, -OCH), 4.44 (d, 1H, J ¼ 8.7 Hz, -OCH), 4.30 (d,
1H, J ¼ 5.7 Hz, -OCH), 3.53 (s, 3H, -OCH3), 3.43 (t, 1H, J ¼ 12.6 Hz, -CH), 2.60 (dd,
1H, J ¼ 8.8 Hz, 13.9 Hz, -CH), 2.06–2.04 (m, 1H, -CH), 1.69–1.58 (m, 2H, 2 � -CH),
1.57–1.48 (m, 2H, 2 � -CH), 1.47–1.38 (m, 2H, 2 � -CH), 1.36–1.25 (m, 2H, 2 � -CH),
1.23 (d, 3H, J ¼ 6.4 Hz, -CH3), 1.09–1.07 (m, 1H, -CH); 13C NMR (75 MHz, CHCl3):
δ 208.8, 170.6, 76.1, 74.4, 73.3, 58.4, 41.3, 33.4, 29.9, 26.5, 23.8, 22.1, 20.8; HRMS (ESI):
m/z calculated for C13H22O5Na [MþNa]þ 281.1367, found 281.1369.
(3R,4R,5S)-((S)-Hex-5-en-2-yl)4-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-5-
(methoxymethoxy)oct-7-enoate (4)
To a solution of acid 5 (0.3 g, 0.68 mmol) and Et3N (0.2 mL, 1.36 mmol) in dry THF
(10 mL) at 0 °C, 2,4,6-trichlorobenzoyl chloride (0.1 mL, 0.68 mmol) in dry THF (3 mL)
was added and stirred at 35 °C for 2 h under a nitrogen atmosphere. It was filtered, and
the filtrate evaporated. The resulting anhydride was dissolved in toluene (3 mL) and treated
with alcohol 6 (0.11 g, 0.68 mmol) in toluene (7 mL), and a catalytic amount of DMAP in
dry toluene (5 mL) was added to the reaction mixture and stirred for 1 h at 35 °C. It was
filtered through celite and washed with toluene (2 � 15 mL). The solvent was evaporated
and the residue was purified by column chromatography (60- to 120-mesh silica gel,
7% EtOAc in petroleum ether) to afford 3 (0.25 g, 70%) as a yellow syrup with 100% dia-
stereoselectivity. ½a�25 ¼ þ 31.7 (c 0.5, CHCl3); IR (neat): 2932, 2857, 1740, 1643, 1462,
D
1
1239, 1096, 919, 776, 698 cmÀ 1; H NMR (300 MHz, CDCl3): δ 7.37–7.27 (m, 5H, ArH-
Bn), 5.93–5.74 (m, 2H, olefinic), 5.13–5.06 (m, 2H, olefinic), 5.04–4.94 (m, 2H, olefinic),